Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results – VACCINES

Fernández, MJL; Narejos, S; Castro, A; Echave-Sustaeta, JM; Forner, MJ; Arana-Arri, E; Molto, J; Bernad, L; Pérez-Caballero, R; Prado, JG; Raïch-Regué, D; Boreika, R; Izquierdo-Useros, N; Trinité, B; Blanco, J; Puig-Barberà, J; Martínez, SN – 2024 – 10.3390/vaccines12080840